Research reports on liver cancer and GC have indicated that pre-treatment levels of ApoB in liver cancer patients are significantly lower compared to those in control groups, suggesting that it may serve as a potential predictor for liver cancer (33). This evidence concerns the gene APOB and liver cancer.